Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours

Abstract

This study demonstrates that SST-mediated growth inhibition is associated with the downregulation of pERK and upregulation of p27. More potent and broader-spectrum SST analogues are likely to play an increasing role in the treatment of tumours, where the MAP kinase pathway is overactivated.